Management of Type 2 Diabetes Mellitus and Kidney Failure in People with HIV-Infection in Africa: Current Status and a Call to Action

References

• UNAIDS. In Danger: UNAIDS global AIDS update 2022; 2022. Available from: https://www.unaids.org/en/resources/documents/2022/in-danger-global-aids-update. Accessed May 9, 2023.
   Google Scholar
• International Diabetes Federation. IDF diabetes atlas 2021 - 10th edition; 2021. Available from: www.diabetesatlas.org. Accessed August 14, 2023.
   Google Scholar
• Erzse A, Stacey N, Chola L, Tugendhaft A, Freeman M, Hofman K. The direct medical cost of type 2 diabetes mellitus in South Africa: a cost of illness study. Glob Health Action. 2019;12(1):1636611. doi:10.1080/16549716.2019.1636611
   PubMed Web of Science ®Google Scholar
• Sun H, Saeedi P, Karuranga S, et al. IDF diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183:109119. doi:10.1016/j.diabres.2021.109119
   PubMed Web of Science ®Google Scholar
• Bello AK, Levin A, Lunney M, et al. Status of care for end stage kidney disease in countries and regions worldwide: international cross sectional survey. BMJ. 2019;367. doi:10.1136/bmj.l5873
   PubMedGoogle Scholar
• Jager KJ, Kovesdy C, Langham R, Rosenberg M, Jha V, Zoccali C. A Single Number for Advocacy and communication—worldwide More Than 850 Million Individuals Have Kidney Diseases. Oxford University Press; 2019:1803–1805.
   Google Scholar
• Bikbov B, Purcell CA, Levey AS, et al. Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the global burden of disease study 2017. Lancet. 2020;395(10225):709–733. doi:10.1016/S0140-6736(20)30045-3
   PubMed Web of Science ®Google Scholar
• Hill NR, Fatoba ST, Oke JL, et al. Global prevalence of chronic kidney disease–a systematic review and meta-analysis. PLoS One. 2016;11(7):e0158765. doi:10.1371/journal.pone.0158765
   PubMed Web of Science ®Google Scholar
• Afkarian M, Sachs MC, Kestenbaum B, et al. Kidney disease and increased mortality risk in type 2 diabetes. J Am Soc Nephrol. 2013;24(2):302–308. doi:10.1681/ASN.2012070718
   PubMed Web of Science ®Google Scholar
• Alicic RZ, Rooney MT, Tuttle KR. Diabetic kidney disease: challenges, progress, and possibilities. Clin J Am Soc Nephrol. 2017;12(12):2032–2045. doi:10.2215/CJN.11491116
   PubMed Web of Science ®Google Scholar
• Noubiap JJN, Naidoo J, Kengne AP. Diabetic nephropathy in Africa: a systematic review. World J Diabetes. 2015;6(5):759. doi:10.4239/wjd.v6.i5.759
   PubMedGoogle Scholar
• Swanepoel CR, Atta MG, D’Agati VD, et al. Kidney disease in the setting of HIV infection: conclusions from a Kidney Disease: improving Global Outcomes (KDIGO) controversies conference. Kidney Int. 2018;93(3):545–559. doi:10.1016/j.kint.2017.11.007
   PubMed Web of Science ®Google Scholar
• Diana NE, Davies M, Mosiane P, Vermeulen A, Naicker S. Clinicopathological correlation of kidney disease in HIV infection pre-and post-ART rollout. PLoS One. 2022;17(5):e0269260. doi:10.1371/journal.pone.0269260
   PubMed Web of Science ®Google Scholar
• Wearne N, Manning K, Price B, et al. The evolving spectrum of kidney histology in HIV-positive patients in South Africa. Kidney Int Rep. 2023;8:1087–1096. doi:10.1016/j.ekir.2023.02.1076
   PubMed Web of Science ®Google Scholar
• Kudose S, Santoriello D, Bomback AS, et al. The spectrum of kidney biopsy findings in HIV-infected patients in the modern era. Kidney Int. 2020;97:1006–1016. doi:10.1016/j.kint.2020.01.018
   PubMed Web of Science ®Google Scholar
• Wearne N, Swanepoel CR, Boulle A, Duffield MS, Rayner BL. The spectrum of renal histologies seen in HIV with outcomes, prognostic indicators and clinical correlations. Nephrol Dial Transplant. 2012;27(11):4109–4118. doi:10.1093/ndt/gfr702
   PubMed Web of Science ®Google Scholar
• Ekrikpo UE, Kengne AP, Bello AK, et al. Chronic kidney disease in the global adult HIV-infected population: a systematic review and meta-analysis. PLoS One. 2018;13(4):e0195443. doi:10.1371/journal.pone.0195443
   PubMed Web of Science ®Google Scholar
• Medapalli R, Parikh CR, Gordon K, et al. Comorbid diabetes and the risk of progressive chronic kidney disease in HIV-infected adults: data from the veterans aging cohort study. J Acquir Immune Defic Syndr. 2012;60(4):393. doi:10.1097/QAI.0b013e31825b70d9
   PubMed Web of Science ®Google Scholar
• Lin YC, Chang YH, Yang SY, Wu KD, Chu TS. Update of pathophysiology and management of diabetic kidney disease. J Formos Med Assoc. 2018;117(8):662–675. doi:10.1016/j.jfma.2018.02.007
   PubMed Web of Science ®Google Scholar
• Alsaad KO, Herzenberg AM. Distinguishing diabetic nephropathy from other causes of glomerulosclerosis: an update. J Clin Pathol. 2007;60(1):18–26. doi:10.1136/jcp.2005.035592
   PubMed Web of Science ®Google Scholar
• Dagar N, Das P, Bisht P, Taraphdar AK, Velayutham R, Arumugam S. Diabetic nephropathy: a twisted thread to unravel. Life Sci. 2021;278:119635. doi:10.1016/j.lfs.2021.119635
   PubMed Web of Science ®Google Scholar
• Raptis AE, Viberti G. Pathogenesis of diabetic nephropathy. Exp Clin Endocrinol Diabetes. 2001;109(Suppl 2):S424–37. doi:10.1055/s-2001-18600
   PubMedGoogle Scholar
• Tuttle KR. Back to the future: glomerular hyperfiltration and the diabetic kidney. Diabetes. 2017;66(1):14–16. doi:10.2337/dbi16-0056
   PubMed Web of Science ®Google Scholar
• Bernhardt WM, Schmitt R, Rosenberger C, et al. Expression of hypoxia-inducible transcription factors in developing human and rat kidneys. Kidney Int. 2006;69(1):114–122. doi:10.1038/sj.ki.5000062
   PubMed Web of Science ®Google Scholar
• Forbes JM, Coughlan MT, Cooper ME. Oxidative stress as a major culprit in kidney disease in diabetes. Diabetes. 2008;57(6):1446–1454. doi:10.2337/db08-0057
   PubMed Web of Science ®Google Scholar
• Ziyadeh FN, Wolf G. Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy. Curr Diabetes Rev. 2008;4(1):39–45. doi:10.2174/157339908783502370
   PubMedGoogle Scholar
• Potenza MA, Gagliardi S, Nacci C, Carratu MR, Montagnani M. Endothelial dysfunction in diabetes: from mechanisms to therapeutic targets. Curr Med Chem. 2009;16(1):94–112. doi:10.2174/092986709787002853
   PubMed Web of Science ®Google Scholar
• Flyvbjerg A. The role of the complement system in diabetic nephropathy. Nat Rev Nephrol. 2017;13(5):311–318. doi:10.1038/nrneph.2017.31
   PubMed Web of Science ®Google Scholar
• Ramana KV. ALDOSE REDUCTASE: new insights for an old enzyme. Biomol Concepts. 2011;2(1–2):103–114. doi:10.1515/BMC.2011.002
   PubMedGoogle Scholar
• Ritz E, Tomaschitz A. Aldosterone, a vasculotoxic agent--novel functions for an old hormone. Nephrol Dial Transplant. 2009;24(8):2302–2305. doi:10.1093/ndt/gfp206
   PubMed Web of Science ®Google Scholar
• Suzuki D, Miyazaki M, Jinde K, et al. In situ hybridization studies of matrix metalloproteinase-3, tissue inhibitor of metalloproteinase-1 and type IV collagen in diabetic nephropathy. Kidney Int. 1997;52(1):111–119. doi:10.1038/ki.1997.310
   PubMed Web of Science ®Google Scholar
• Sarkar S, Brown TT. Diabetes in people with HIV. Curr Diab Rep. 2021;21(5):13. doi:10.1007/s11892-021-01382-8
   PubMed Web of Science ®Google Scholar
• Dave JA, Lambert EV, Badri M, West S, Maartens G, Levitt NS. Effect of nonnucleoside reverse transcriptase inhibitor-based antiretroviral therapy on dysglycemia and insulin sensitivity in South African HIV-infected patients. J Acquir Immune Defic Syndr. 2011;57(4):284–289. doi:10.1097/QAI.0b013e318221863f
   PubMed Web of Science ®Google Scholar
• Prioreschi A, Munthali RJ, Soepnel L, et al. Incidence and prevalence of type 2 diabetes mellitus with HIV infection in Africa: a systematic review and meta-analysis. BMJ Open. 2017;7(3):e013953. doi:10.1136/bmjopen-2016-013953
   PubMed Web of Science ®Google Scholar
• Carr A, Samaras K, Burton S, et al. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS. 1998;12(7):F51–8. doi:10.1097/00002030-199807000-00003
   PubMed Web of Science ®Google Scholar
• Hadigan C, Corcoran C, Stanley T, Piecuch S, Klibanski A, Grinspoon S. Fasting hyperinsulinemia in human immunodeficiency virus-infected men: relationship to body composition, gonadal function, and protease inhibitor use. J Clin Endocrinol Metab. 2000;85(1):35–41. doi:10.1210/jcem.85.1.6264
   PubMed Web of Science ®Google Scholar
• Hadigan C, Miller K, Corcoran C, Anderson E, Basgoz N, Grinspoon S. Fasting hyperinsulinemia and changes in regional body composition in human immunodeficiency virus-infected women. J Clin Endocrinol Metab. 1999;84(6):1932–1937. doi:10.1210/jcem.84.6.5738
   PubMed Web of Science ®Google Scholar
• Levitt NS, Peer N, Steyn K, et al. Increased risk of dysglycaemia in South Africans with HIV; especially those on protease inhibitors. Diabetes Res Clin Pract. 2016;119:41–47. doi:10.1016/j.diabres.2016.03.012
   PubMed Web of Science ®Google Scholar
• Brown TT, Cole SR, Li X, et al. Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study. Arch Intern Med. 2005;165(10):1179–1184. doi:10.1001/archinte.165.10.1179
   PubMedGoogle Scholar
• Echecopar-Sabogal J, D’Angelo-Piaggio L, Chanamé-Baca DM, Ugarte-Gil C. Association between the use of protease inhibitors in highly active antiretroviral therapy and incidence of diabetes mellitus and/or metabolic syndrome in HIV-infected patients: a systematic review and meta-analysis. Int J STD AIDS. 2018;29(5):443–452. doi:10.1177/0956462417732226
   PubMed Web of Science ®Google Scholar
• Murata H, Hruz PW, Mueckler M. The mechanism of insulin resistance caused by HIV protease inhibitor therapy. J Biol Chem. 2000;275(27):20251–20254. doi:10.1074/jbc.C000228200
   PubMed Web of Science ®Google Scholar
• Limone P, Biglino A, Valle M, et al. Insulin resistance in HIV-infected patients: relationship with pro-inflammatory cytokines released by peripheral leukocytes. J Infect. 2003;47(1):52–58. doi:10.1016/s0163-4453(03)00055-0
   PubMed Web of Science ®Google Scholar
• Lagathu C, Kim M, Maachi M, et al. HIV antiretroviral treatment alters adipokine expression and insulin sensitivity of adipose tissue in vitro and in vivo. Biochimie. 2005;87(1):65–71. doi:10.1016/j.biochi.2004.12.007
   PubMed Web of Science ®Google Scholar
• Lindegaard B, Keller P, Bruunsgaard H, Gerstoft J, Pedersen BK. Low plasma level of adiponectin is associated with stavudine treatment and lipodystrophy in HIV-infected patients. Clin Exp Immunol. 2004;135(2):273–279. doi:10.1111/j.1365-2249.2004.02367.x
   PubMed Web of Science ®Google Scholar
• Kanters S, Renaud F, Rangaraj A, et al. Evidence synthesis evaluating body weight gain among people treating HIV with antiretroviral therapy - a systematic literature review and network meta-analysis. EClinicalMedicine. 2022;48:101412. doi:10.1016/j.eclinm.2022.101412
   PubMedGoogle Scholar
• Venter WDF, Moorhouse M, Sokhela S, et al. Dolutegravir plus two different prodrugs of tenofovir to treat HIV. N Engl J Med. 2019;381(9):803–815. doi:10.1056/NEJMoa1902824
   PubMed Web of Science ®Google Scholar
• Kajogoo VD, Amogne W, Medhin G. New onset type 2 diabetes mellitus risks with integrase strand transfer inhibitors-based regimens: a systematic review and meta-analysis. Metabol Open. 2023;17:100235. doi:10.1016/j.metop.2023.100235
   PubMedGoogle Scholar
• Mulindwa F, Kamal H, Castelnuovo B, et al. Association between integrase strand transfer inhibitor use with insulin resistance and incident diabetes mellitus in persons living with HIV: a systematic review and meta-analysis. BMJ Open Diabet Res Care. 2023;11(1):e003136. doi:10.1136/bmjdrc-2022-003136
   PubMed Web of Science ®Google Scholar
• Berliner AR, Fine DM, Lucas GM, et al. Observations on a cohort of HIV-infected patients undergoing native renal biopsy. Am J Nephrol. 2008;28(3):478–486. doi:10.1159/000112851
   PubMed Web of Science ®Google Scholar
• Szczech LA, Gupta SK, Habash R, et al. The clinical epidemiology and course of the spectrum of renal diseases associated with HIV infection. Kidney Int. 2004;66(3):1145–1152. doi:10.1111/j.1523-1755.2004.00865.x
   PubMed Web of Science ®Google Scholar
• Laster M, Shen JI, Norris KC. Kidney disease among African Americans: a population perspective. Am J Kidney Dis. 2018;72(5):S3–S7. doi:10.1053/j.ajkd.2018.06.021
   PubMed Web of Science ®Google Scholar
• Genovese G, Friedman DJ, Ross MD, et al. Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science. 2010;329(5993):841–845. doi:10.1126/science.1193032
   PubMed Web of Science ®Google Scholar
• Hung RK, Binns-Roemer E, Booth JW, et al. Genetic variants of APOL1 are major determinants of kidney failure in people of African ancestry with HIV. Kidney Int Rep. 2022;7(4):786–796. doi:10.1016/j.ekir.2022.01.1054
   PubMed Web of Science ®Google Scholar
• Limou S, Nelson GW, Kopp JB, Winkler CA. APOL1 kidney risk alleles: population genetics and disease associations. Adv Chronic Kidney Dis. 2014;21(5):426–433. doi:10.1053/j.ackd.2014.06.005
   PubMed Web of Science ®Google Scholar
• Kopp JB, Heymann J, Winkler CA. APOL1 Renal Risk Variants: Fertile Soil for HIV-Associated Nephropathy. Elsevier; 2017:514–519.
   Google Scholar
• Akinbodewa AA, Adejumo AO, Koledoye OV, et al. Community screening for pre-hypertension, traditional risk factors and markers of chronic kidney disease in Ondo State, South-Western Nigeria. Niger Postgrad Med J. 2017;24(1):25–30. doi:10.4103/npmj.npmj_161_16
   PubMedGoogle Scholar
• Freedman BI, Murea M. Target organ damage in African American hypertension: role of APOL1. Curr Hypertens Rep. 2012;14:21–28. doi:10.1007/s11906-011-0237-4
   PubMed Web of Science ®Google Scholar
• Friedman DJ, Pollak MR. APOL1 nephropathy: from genetics to clinical applications. Clin J Am Soc Nephrol. 2021;16(2):294–303. doi:10.2215/CJN.15161219
   PubMed Web of Science ®Google Scholar
• Osafo C, Raji YR, Olanrewaju T, et al. Genomic approaches to the burden of kidney disease in sub-Saharan Africa: the human heredity and health in Africa (H3Africa) kidney disease research network. Kidney Int. 2016;90(1):2–5. doi:10.1016/j.kint.2015.12.059
   PubMed Web of Science ®Google Scholar
• Retnakaran R, Cull CA, Thorne KI, Adler AI, Holman RR, Group US. Risk factors for renal dysfunction in type 2 diabetes: U.K. prospective diabetes study 74. Diabetes. 2006;55(6):1832–1839. doi:10.2337/db05-1620
   PubMed Web of Science ®Google Scholar
• Adler AI, Stevens RJ, Manley SE, et al. Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int. 2003;63(1):225–232. doi:10.1046/j.1523-1755.2003.00712.x
   PubMed Web of Science ®Google Scholar
• Afkarian M, Zelnick LR, Hall YN, et al. Clinical manifestations of kidney disease among US adults with diabetes, 1988–2014. JAMA. 2016;316(6):602–610. doi:10.1001/jama.2016.10924
   PubMed Web of Science ®Google Scholar
• Choi AI, Rodriguez RA, Bacchetti P, Bertenthal D, Volberding PA, O’Hare AM. Racial differences in end-stage renal disease rates in HIV infection versus diabetes. J Am Soc Nephrol. 2007;18(11):2968–2974. doi:10.1681/ASN.2007040402
   PubMed Web of Science ®Google Scholar
• Kousignian I, Sautereau A, Vigouroux C, et al. Diagnosis, risk factors and management of diabetes mellitus in HIV-infected persons in France: a real-life setting study. PLoS One. 2021;16(5):e0250676. doi:10.1371/journal.pone.0250676
   PubMed Web of Science ®Google Scholar
• Pillay S, Mahomed F, Aldous C. A deadly combination-HIV and diabetes mellitus: where are we now? S Afr Med J. 2016;106(4):378–383. doi:10.7196/SAMJ.2016.v106i4.9950
   Google Scholar
• Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–612. doi:10.7326/0003-4819-150-9-200905050-00006
   PubMed Web of Science ®Google Scholar
• Inker LA, Eneanya ND, Coresh J, et al. New creatinine-and cystatin C–based equations to estimate GFR without race. N Engl J Med. 2021;385(19):1737–1749. doi:10.1056/NEJMoa2102953
   PubMed Web of Science ®Google Scholar
• Fabian J, Kalyesubula R, Mkandawire J, et al. Measurement of kidney function in Malawi, South Africa, and Uganda: a multicentre cohort study. Lancet Glob Health. 2022;10(8):e1159–e1169. doi:10.1016/S2214-109X(22)00239-X
   PubMed Web of Science ®Google Scholar
• Han JH, Gordon K, Womack JA, et al. Comparative effectiveness of diabetic oral medications among HIV-infected and HIV-uninfected veterans. Diabet Care. 2017;40(2):218–225. doi:10.2337/dc16-0718
   PubMed Web of Science ®Google Scholar
• Song IH, Zong J, Borland J, et al. The effect of dolutegravir on the pharmacokinetics of metformin in healthy subjects. J Acquir Immune Defic Syndr. 2016;72(4):400–407. doi:10.1097/QAI.0000000000000983
   PubMed Web of Science ®Google Scholar
• Schwenk MH. Seyffart’s directory of drug dosage in kidney disease. Kidney Int. 2012;81(10):931–932. doi:10.1038/ki.2012.57
   Google Scholar
• Merative Micromedex® DRUGDEX® (electronic version). Merative, Ann Arbor, Michigan, USA; 2023. Available from: https://www.micromedexsolutions.com/. Accessed May 19, 2023.
   Google Scholar
• Alicic RZ, Neumiller JJ, Galindo RJ, Tuttle KR. Use of glucose-lowering agents in diabetes and CKD. Kidney Int Rep. 2022;7(12):2589–2607. doi:10.1016/j.ekir.2022.09.018
   PubMed Web of Science ®Google Scholar
• Rossing P, Caramori ML, Chan JCN, et al. Executive summary of the KDIGO 2022 Clinical practice guideline for diabetes management in chronic kidney disease: an update based on rapidly emerging new evidence. Kidney Int. 2022;102(5):990–999. doi:10.1016/j.kint.2022.06.013
   PubMed Web of Science ®Google Scholar
• South African Medicine Association. South African Medicine Formulary. South African Medicine Association; 2022.
   Google Scholar
• Post FA. Managing chronic kidney disease in the older adults living with HIV. Curr Opin Infect Dis. 2017;30(1):4–11. doi:10.1097/QCO.0000000000000333
   PubMed Web of Science ®Google Scholar
• UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352(9131):837–853. doi:10.1016/S0140-6736(98)07019-6
   PubMed Web of Science ®Google Scholar
• Lv J, Perkovic V, Foote CV, Craig ME, Craig JC, Strippoli GF. Antihypertensive agents for preventing diabetic kidney disease. Cochrane Database Syst Rev. 2012;12:Cd004136. doi:10.1002/14651858.CD004136.pub3
   PubMedGoogle Scholar
• UK Prospective Diabetes Study (UKPDS) Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ. 1998;317(7160):703–713. doi:10.1136/bmj.317.7160.703
   PubMed Web of Science ®Google Scholar
• Hirst JA, Taylor KS, Stevens RJ, et al. The impact of renin-angiotensin-aldosterone system inhibitors on type 1 and type 2 diabetic patients with and without early diabetic nephropathy. Kidney Int. 2012;81(7):674–683. doi:10.1038/ki.2011.413
   PubMed Web of Science ®Google Scholar
• Wang K, Hu J, Luo T, et al. Effects of angiotensin-converting enzyme inhibitors and angiotensin ii receptor blockers on all-cause mortality and renal outcomes in patients with diabetes and albuminuria: a systematic review and meta-analysis. Kidney Blood Press Res. 2018;43(3):768–779. doi:10.1159/000489913
   PubMed Web of Science ®Google Scholar
• Yahaya I, Uthman OA, Uthman MM. Interventions for HIV-associated nephropathy. Cochrane Database Syst Rev. 2013;2013(1):CD007183. doi:10.1002/14651858.CD007183.pub3
   PubMedGoogle Scholar
• Ahuja TS, Grady J, Khan S. Changing trends in the survival of dialysis patients with human immunodeficiency virus in the United States. J Am Soc Nephrol. 2002;13(7):1889–1893. doi:10.1097/01.ASN.0000019773.43765.BF
   PubMed Web of Science ®Google Scholar
• Jardine T, Wong E, Steenkamp R, Caskey FJ, Davids MR. Survival of South African patients on renal replacement therapy. Clin Kidney J. 2020;13(5):782–790. doi:10.1093/ckj/sfaa012
   PubMed Web of Science ®Google Scholar
• Ozener C, Arikan H, Karayaylali I, et al. The impact of diabetes mellitus on peritoneal dialysis: the Turkey Multicenter Clinic Study. Ren Fail. 2014;36(2):149–153. doi:10.3109/0886022X.2013.843275
   PubMed Web of Science ®Google Scholar
• Locatelli F, Del Vecchio L, Cavalli A. How Can Prognosis for Diabetic ESRD Be Improved? Wiley Online Library; 2010:214–219.
   Google Scholar
• Passadakis PS, Oreopoulos DG. Diabetic Patients on Peritoneal Dialysis. Wiley Online Library; 2010:191–197.
   Google Scholar
• Yang X, Yi C, Liu X, et al. Clinical outcome and risk factors for mortality in Chinese patients with diabetes on peritoneal dialysis: a 5-year clinical cohort study. Diabetes Res Clin Pract. 2013;100(3):354–361. doi:10.1016/j.diabres.2013.03.030
   PubMed Web of Science ®Google Scholar
• Fang W, Qian J, Lin A, et al. Comparison of peritoneal dialysis practice patterns and outcomes between a Canadian and a Chinese centre. Nephrol Dial Transplant. 2008;23(12):4021–4028. doi:10.1093/ndt/gfn372
   PubMed Web of Science ®Google Scholar
• Pk-t L, Szeto -C-C. Success of the Peritoneal Dialysis Programme in Hong Kong. Oxford University Press; 2008.
   Google Scholar
• Tien K-J, Lin -Z-Z, Chio -C-C, et al. Epidemiology and mortality of new-onset diabetes after dialysis: Taiwan national cohort study. Diabet Care. 2013;36(10):3027–3032. doi:10.2337/dc12-2148
   PubMed Web of Science ®Google Scholar
• Sattar A, Argyropoulos C, Weissfeld L, et al. All-cause and cause-specific mortality associated with diabetes in prevalent hemodialysis patients. BMC Nephrol. 2012;13:1–9. doi:10.1186/1471-2369-13-130
   PubMed Web of Science ®Google Scholar
• Soleymanian T, Raman S, Shannaq FN, et al. Survival and morbidity of HIV patients on hemodialysis and peritoneal dialysis: one center’s experience and review of the literature. Int Urol Nephrol. 2006;38:331–338. doi:10.1007/s11255-006-0080-8
   PubMed Web of Science ®Google Scholar
• Xue J, Li H, Zhou Q, Wen S, Zhou Q, Chen W. Comparison of peritoneal dialysis with hemodialysis on survival of diabetic patients with end-stage kidney disease: a meta-analysis of cohort studies. Ren Fail. 2019;41(1):521–531. doi:10.1080/0886022X.2019.1625788
   PubMed Web of Science ®Google Scholar
• Han SS, Park JY, Kang S, et al. Dialysis modality and mortality in the elderly: a meta-analysis. Clin J Am Soc Nephrol. 2015;10(6):983–993. doi:10.2215/CJN.05160514
   PubMed Web of Science ®Google Scholar
• Zhang D, Yang Y, Li R, et al. Comparison of long-term outcomes between Chinese peritoneal dialysis patients with and without diabetes: a 10-year cohort study. J Diabetes Complications. 2021;35(5):107888. doi:10.1016/j.jdiacomp.2021.107888
   PubMed Web of Science ®Google Scholar
• Sieg SF, Shive CL, Panigrahi S, Freeman ML. Probing the interface of HIV and inflammaging. Curr HIV. 2021;18:198–210. doi:10.1007/s11904-021-00547-0
   PubMed Web of Science ®Google Scholar
• Deeks SG. HIV infection, inflammation, immunosenescence, and aging. Annu Rev Med. 2011;62:141–155. doi:10.1146/annurev-med-042909-093756
   PubMed Web of Science ®Google Scholar
• Manner IW, Baekken M, Oektedalen O, Os I. Hypertension and antihypertensive treatment in HIV-infected individuals. A longitudinal cohort study. Blood Press. 2012;21(5):311–319. doi:10.3109/08037051.2012.680742
   PubMed Web of Science ®Google Scholar
• Borkum M, Heckmann J, Manning K, et al. High prevalence of “non-dipping” blood pressure and vascular stiffness in HIV-infected South Africans on antiretrovirals. PLoS One. 2017;12(9):e0185003. doi:10.1371/journal.pone.0185003
   PubMed Web of Science ®Google Scholar
• De Jager J, Dekker JM, Kooy A, et al. Endothelial dysfunction and low-grade inflammation explain much of the excess cardiovascular mortality in individuals with type 2 diabetes: the Hoorn Study. Arterioscler Thromb Vasc Biol. 2006;26(5):1086–1093. doi:10.1161/01.ATV.0000215951.36219.a4
   PubMed Web of Science ®Google Scholar
• Mitchell D, Krishnasami Z, Young CJ, Allon M. Arteriovenous access outcomes in haemodialysis patients with HIV infection. Nephrol Dial Transplant. 2007;22(2):465–470. doi:10.1093/ndt/gfl629
   PubMed Web of Science ®Google Scholar
• Dicken QG, Cheng TW, Farber A, et al. Patients with human immunodeficiency virus infection do not have inferior outcomes after dialysis access creation. J Vasc Surg. 2020;72(6):2113–2119. doi:10.1016/j.jvs.2020.03.030
   PubMed Web of Science ®Google Scholar
• Johansen KL, Chertow GM, Gilbertson DT, et al. US renal data system 2021 annual data report: epidemiology of kidney disease in the United States. Am J Kidney Dis. 2022;79(4):A8–A12. doi:10.1053/j.ajkd.2022.02.001
   PubMed Web of Science ®Google Scholar
• Zou M, Xie J, Lan L, et al. Safety and efficacy of hemodialysis and peritoneal dialysis in treating end-stage diabetic nephropathy: a meta-analysis of randomized controlled trials. Int Urol Nephrol. 2022;54(11):2901–2909. doi:10.1007/s11255-022-03194-5
   PubMed Web of Science ®Google Scholar
• Sigrist M, Bungay P, Taal MW, McIntyre CW. Vascular calcification and cardiovascular function in chronic kidney disease. Nephrol Dial Transplant. 2006;21(3):707–714. doi:10.1093/ndt/gfi236
   PubMed Web of Science ®Google Scholar
• Stock PG, Barin B, Murphy B, et al. Outcomes of kidney transplantation in HIV-infected recipients. N Engl J Med. 2010;363(21):2004–2014. doi:10.1056/NEJMoa1001197
   PubMed Web of Science ®Google Scholar
• Muller E, Barday Z, Mendelson M, Kahn D. HIV-positive–to–HIV-positive kidney transplantation—results at 3 to 5 years. N Engl J Med. 2015;372(7):613–620. doi:10.1056/NEJMoa1408896
   PubMed Web of Science ®Google Scholar
• Locke JE, Gustafson S, Mehta S, et al. Survival benefit of kidney transplantation in HIV-infected patients. Ann Surg. 2017;265(3):604. doi:10.1097/SLA.0000000000001761
   PubMed Web of Science ®Google Scholar
• Adekunle RO, Zhang R, Wang Z, Patzer RE, Mehta AK. Early steps to kidney transplantation among persons with HIV and end‐stage renal disease in ESRD network 6. Transpl Infect Dis. 2022;24(1):e13767. doi:10.1111/tid.13767
   PubMed Web of Science ®Google Scholar
• Lim WH, Wong G, Pilmore HL, McDonald SP, Chadban SJ. Long-term outcomes of kidney transplantation in people with type 2 diabetes: a population cohort study. Lancet Diabet Endocrinol. 2017;5(1):26–33. doi:10.1016/S2213-8587(16)30317-5
   PubMed Web of Science ®Google Scholar
• Kasiske BL, Snyder JJ, Gilbertson D, Matas AJ. Diabetes mellitus after kidney transplantation in the United States. Am J Transplant. 2003;3(2):178–185. doi:10.1034/j.1600-6143.2003.00010.x
   PubMed Web of Science ®Google Scholar
• Kuo H-T, Sampaio MS, Vincenti F, Bunnapradist S. Associations of pretransplant diabetes mellitus, new-onset diabetes after transplant, and acute rejection with transplant outcomes: an analysis of the Organ Procurement and Transplant Network/United Network for Organ Sharing (OPTN/UNOS) database. Am J Kidney Dis. 2010;56(6):1127–1139. doi:10.1053/j.ajkd.2010.06.027
   PubMed Web of Science ®Google Scholar
• Barday Z, Manning K, Freercks R, Bertels L, Wearne N, Muller E. Retrospective review of ART regimens in HIV-positive to HIV-positive kidney transplant recipients. Kidney Int Rep. 2022;7(9):2039–2046. doi:10.1016/j.ekir.2022.06.013
   PubMed Web of Science ®Google Scholar
• Muller E, Botha FC, Barday ZA, Manning K, Chin-Hong P, Stock P. Kidney transplantation in HIV-positive patients: current practice and management strategies. Transplantation. 2021;105(7):1492–1501. doi:10.1097/TP.0000000000003485
   PubMed Web of Science ®Google Scholar
• Liyanage T, Ninomiya T, Jha V, et al. Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet. 2015;385(9981):1975–1982. doi:10.1016/S0140-6736(14)61601-9
   PubMed Web of Science ®Google Scholar
• Jha V, Garcia-Garcia G, Iseki K, et al. Chronic kidney disease: global dimension and perspectives. Lancet. 2013;382(9888):260–272. doi:10.1016/S0140-6736(13)60687-X
   PubMed Web of Science ®Google Scholar
• Davison SN, Levin A, Moss AH, et al. Executive summary of the KDIGO controversies conference on supportive care in chronic kidney disease: developing a roadmap to improving quality care. Kidney Int. 2015;88(3):447–459. doi:10.1038/ki.2015.110
   PubMed Web of Science ®Google Scholar
• Smith S, Brick A, O’Hara S, Normand C. Evidence on the cost and cost-effectiveness of palliative care: a literature review. Palliat Med. 2014;28(2):130–150. doi:10.1177/0269216313493466
   PubMed Web of Science ®Google Scholar
• Wearne N, Davidson B, Mc Culloch M, Krause R, Krause R. Radically rethinking renal supportive and palliative Care in South Africa. Kidney Int Rep. 2021;6(3):568–573. doi:10.1016/j.ekir.2020.11.024
   PubMed Web of Science ®Google Scholar